- Home
- RAPT vs MGRM Comparison
RAPT vs MGRM Comparison
Compare RAPT & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- MGRM
- Stock Information
- Founded
- RAPT 2015
- MGRM 2016
- Country
- RAPT United States
- MGRM United States
- Employees
- RAPT N/A
- MGRM N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- MGRM Medical/Dental Instruments
- Sector
- RAPT Health Care
- MGRM Health Care
- Exchange
- RAPT Nasdaq
- MGRM Nasdaq
- Market Cap
- RAPT 194.2M
- MGRM 232.0M
- IPO Year
- RAPT 2019
- MGRM N/A
- Fundamental
- Price
- RAPT $13.18
- MGRM $5.74
- Analyst Decision
- RAPT Buy
- MGRM Strong Buy
- Analyst Count
- RAPT 5
- MGRM 1
- Target Price
- RAPT $33.60
- MGRM $5.40
- AVG Volume (30 Days)
- RAPT 117.5K
- MGRM 126.7K
- Earning Date
- RAPT 08-07-2025
- MGRM 08-15-2025
- Dividend Yield
- RAPT N/A
- MGRM N/A
- EPS Growth
- RAPT N/A
- MGRM N/A
- EPS
- RAPT N/A
- MGRM N/A
- Revenue
- RAPT N/A
- MGRM N/A
- Revenue This Year
- RAPT N/A
- MGRM N/A
- Revenue Next Year
- RAPT N/A
- MGRM N/A
- P/E Ratio
- RAPT N/A
- MGRM N/A
- Revenue Growth
- RAPT N/A
- MGRM N/A
- 52 Week Low
- RAPT $5.67
- MGRM $1.92
- 52 Week High
- RAPT $26.56
- MGRM $6.02
- Technical
- Relative Strength Index (RSI)
- RAPT 63.64
- MGRM 61.07
- Support Level
- RAPT $11.19
- MGRM $5.67
- Resistance Level
- RAPT $13.66
- MGRM $6.02
- Average True Range (ATR)
- RAPT 0.75
- MGRM 0.16
- MACD
- RAPT 0.19
- MGRM -0.02
- Stochastic Oscillator
- RAPT 86.53
- MGRM 61.85
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.